Pinned Tweet
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking JU and others. Any related tweets reflect only the views of the author.
1
1
8
📢 New deliverable out!
👉D2.12 Final Progress Report Task 2.2
🔗loom.ly/7VgoMbs
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
👉D2.12 Final Progress Report Task 2.2
🔗loom.ly/7VgoMbs
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
0
0
1
57
📢 New deliverable out!
👉D2.4 Report on identification of adverse events for safety evaluations of RSV vaccination and monoclonal antibodies
🔗loom.ly/r8UCJOE
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
👉D2.4 Report on identification of adverse events for safety evaluations of RSV vaccination and monoclonal antibodies
🔗loom.ly/r8UCJOE
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
0
1
2
97
📢 New deliverable out!
👉D2.8 Identification of methodological challenges
🔗loom.ly/_WjRoNY
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
👉D2.8 Identification of methodological challenges
🔗loom.ly/_WjRoNY
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
0
0
0
57
📢 New deliverable out!
👉D1.5 Report on global impact of COVID-19 on RSV burden
🔗 loom.ly/lbimvZw
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
👉D1.5 Report on global impact of COVID-19 on RSV burden
🔗 loom.ly/lbimvZw
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
0
0
2
79
📢 New deliverable out!
👉 D1.3 Report on RSV burden in pregnant women
🔗 loom.ly/YIKIAoo
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
👉 D1.3 Report on RSV burden in pregnant women
🔗 loom.ly/YIKIAoo
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
0
1
2
104
📢 New deliverable out!
👉 D1.2 Report on variation in global RSV seasonality by subtypes
🔗 loom.ly/7QS9wZk
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
👉 D1.2 Report on variation in global RSV seasonality by subtypes
🔗 loom.ly/7QS9wZk
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
0
1
3
98
📢 New deliverable out!
👉 D1.1 Report on novel clinical scores for RSV severity
🔗 loom.ly/jpT7xxk
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
👉 D1.1 Report on novel clinical scores for RSV severity
🔗 loom.ly/jpT7xxk
#PROMISE #RSV #RSVPatientNetwork
@CCVernhes @IHIEurope @ReSViNET @PagetPhd
0
1
1
179
@PROMISE_IMI European hashtag #RSV Surveillance Bulletin #16⤵
“France, Portugal and Slovenia reported sporadic RSV activity. Austria, Belgium and the Netherlands reported baseline RSV activity.”
Full bulletin here 🔗imi-promise.eu/surveillance/p…
“France, Portugal and Slovenia reported sporadic RSV activity. Austria, Belgium and the Netherlands reported baseline RSV activity.”
Full bulletin here 🔗imi-promise.eu/surveillance/p…
0
1
2
241
@PROMISE_IMI European hashtag #RSV Surveillance Bulletin #14⤵
“In reporting week 14 Austria, France and Portugal and Slovenia reported sporadic RSV activity. Belgium, Denmark and the Netherlands reported baseline RSV activity.”
Full bulletin here 👉imi-promise.eu/surveillance/p…
“In reporting week 14 Austria, France and Portugal and Slovenia reported sporadic RSV activity. Belgium, Denmark and the Netherlands reported baseline RSV activity.”
Full bulletin here 👉imi-promise.eu/surveillance/p…
0
2
2
203
@PROMISE_IMI European hashtag #RSV Surveillance Bulletin #12⤵
“In week 12, Slovenia reported RSV activity. Austria, France and Portugal reported sporadic RSV activity. Belgium, Denmark and the Netherlands reported baseline RSV activity.”
👉imi-promise.eu/surveillance/p…
“In week 12, Slovenia reported RSV activity. Austria, France and Portugal reported sporadic RSV activity. Belgium, Denmark and the Netherlands reported baseline RSV activity.”
👉imi-promise.eu/surveillance/p…
0
2
4
242
Our focus always remained clear: to develop innovative immunisation tools and therapeutics to combat this potentially deadly virus, especially in our paediatric and elderly populations👶👵
Thank you everyone for your support & participation to date!
@IHIEurope
Thank you everyone for your support & participation to date!
@IHIEurope
Celebrating the achievements of the @PROMISE_IMI, including the European #RSV surveillance bulletin published biweekly since October 2023, which has benefited from continuous improvement since its launch thanks to collaborative work with partners.
0
1
10
319
Dr.Edoardo Colzani highlights the urgent need for more Respiratory Syncytial Virus research and better surveillance for older adults.
With #RSV set to become notifiable disease in the EU, it's time for action. 🛡️
Watch the full webinar here:loom.ly/_0rgIAU
@ihieurope
With #RSV set to become notifiable disease in the EU, it's time for action. 🛡️
Watch the full webinar here:loom.ly/_0rgIAU
@ihieurope
0
0
0
62
The path to combatting Respiratory Syncytial Virus (#RSV) lies in highlighting the importance of vaccination to our policymakers.
Investing in RSV vaccines is not just a measure of immediate protection but a long-term strategy to safeguard us all. 🏘️
ℹ️: loom.ly/_0rgIAU
Investing in RSV vaccines is not just a measure of immediate protection but a long-term strategy to safeguard us all. 🏘️
ℹ️: loom.ly/_0rgIAU
0
3
7
279
At the PROMISE webinar, the call for action was clear: adopting #RSV prevention strategies is a moral duty. Our healthcare must protect the most vulnerable - infants and the elderly. 🛡️
💬 Explore the full debate: loom.ly/_0rgIAU
@ihieurope @sanofi @TeamItResearch
💬 Explore the full debate: loom.ly/_0rgIAU
@ihieurope @sanofi @TeamItResearch
0
0
1
54
#RSV is now preventable. Member States must act to get prevention tools where they're needed most.
Let's tackle this together. 🩺🇪🇺
Watch the full webinar: imi-promise.eu/dissemination/…
@ihieurope @sanofi @TeamItResearch @fedemartinon
Let's tackle this together. 🩺🇪🇺
Watch the full webinar: imi-promise.eu/dissemination/…
@ihieurope @sanofi @TeamItResearch @fedemartinon
0
8
8
1,172
European #RSV Surveillance Bulletin #10⤵
“Austria, Denmark, France and the Netherlands reported that the trend in percentage of RSV positive cases is decreasing. The trend in percentage of RSV positive cases remains stable in Slovenia.”
👉imi-promise.eu/surveillance/p…
“Austria, Denmark, France and the Netherlands reported that the trend in percentage of RSV positive cases is decreasing. The trend in percentage of RSV positive cases remains stable in Slovenia.”
👉imi-promise.eu/surveillance/p…
0
0
1
112
Dr. Edoardo Colzani calls for more research and better surveillance to combat RSV, especially in older adults.
With RSV on track to become a notifiable disease in the EU, we're at a critical juncture. 🏥
Discover the full debate, here: loom.ly/_0rgIAU
@IHIEurope
With RSV on track to become a notifiable disease in the EU, we're at a critical juncture. 🏥
Discover the full debate, here: loom.ly/_0rgIAU
@IHIEurope
0
4
5
488
By incorporating #RSV consequences into economic assessments, we can improve decision-making and enhance national responses. 💶
Delve into this and other insights from Prof. Dr. med. Monika Gappa, from the @EuroRespSoc: imi-promise.eu/dissemination/…
Delve into this and other insights from Prof. Dr. med. Monika Gappa, from the @EuroRespSoc: imi-promise.eu/dissemination/…
0
2
4
265
Exciting news! 🌟
Would you like to know what the @PROMISE_IMI Project has been doing in #RespiratorySynctialVirus (#RSV) for the past 8 years?
Learn more about the recent supplement in The Journal of Infectious Diseases (@IDSAInfo)
More info 👉 imi-promise.eu/news/exciting-…
Would you like to know what the @PROMISE_IMI Project has been doing in #RespiratorySynctialVirus (#RSV) for the past 8 years?
Learn more about the recent supplement in The Journal of Infectious Diseases (@IDSAInfo)
More info 👉 imi-promise.eu/news/exciting-…
1
8
12
691
It's worth noting that sister predecessor @RESCEUproject played a great role in the progress made to date.
0
0
1
36